The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-[(2S)-1-[6-[(6,7-difluoro-1H-benzimidazol-2-yl)methylamino]-9-ethyl-purin-2-yl]-2-piperidyl]ethanol ID: ALA4649135
PubChem CID: 131953498
Max Phase: Preclinical
Molecular Formula: C22H26F2N8O
Molecular Weight: 456.50
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CCn1cnc2c(NCc3nc4ccc(F)c(F)c4[nH]3)nc(N3CCCC[C@H]3CCO)nc21
Standard InChI: InChI=1S/C22H26F2N8O/c1-2-31-12-26-19-20(25-11-16-27-15-7-6-14(23)17(24)18(15)28-16)29-22(30-21(19)31)32-9-4-3-5-13(32)8-10-33/h6-7,12-13,33H,2-5,8-11H2,1H3,(H,27,28)(H,25,29,30)/t13-/m0/s1
Standard InChI Key: HVFVQLFPRQYJTR-ZDUSSCGKSA-N
Molfile:
RDKit 2D
33 37 0 0 0 0 0 0 0 0999 V2000
29.7539 -13.1685 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.4619 -12.7571 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.1702 -13.1679 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.1702 -13.9874 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.4644 -14.3939 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.7539 -13.9885 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.1496 -14.5405 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.4868 -15.2839 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.2981 -15.1963 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.3576 -14.3285 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.7777 -14.9083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.8782 -14.3950 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.5863 -13.9874 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.2944 -14.3950 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.0451 -14.0637 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.5926 -14.6689 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.1811 -15.3806 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.3836 -15.2075 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.5913 -16.0922 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.4094 -16.0851 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.8157 -15.3814 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.4079 -14.6696 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.8156 -13.9615 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
36.6352 -15.3814 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
30.4619 -11.9377 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.7538 -11.5300 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.7538 -10.7106 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.4619 -10.3029 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.1699 -10.7106 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.1699 -11.5300 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.0457 -11.9377 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.3335 -11.5300 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.6255 -11.9377 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 2 0
5 4 1 0
6 5 2 0
1 6 1 0
6 7 1 0
8 7 1 0
9 8 2 0
5 9 1 0
7 10 1 0
10 11 1 0
4 12 1 0
12 13 1 0
13 14 1 0
15 14 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 14 2 0
17 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
16 22 1 0
22 23 1 0
21 24 1 0
25 2 1 0
25 26 1 0
27 26 1 0
28 27 1 0
29 28 1 0
30 29 1 0
25 30 1 0
26 31 1 6
31 32 1 0
32 33 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 456.50Molecular Weight (Monoisotopic): 456.2198AlogP: 3.35#Rotatable Bonds: 7Polar Surface Area: 107.78Molecular Species: NEUTRALHBA: 8HBD: 3#RO5 Violations: ┄HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 9.60CX Basic pKa: 5.58CX LogP: 2.79CX LogD: 2.78Aromatic Rings: 4Heavy Atoms: 33QED Weighted: 0.39Np Likeness Score: -1.27
References 1. Cheng W, Yang Z, Wang S, Li Y, Wei H, Tian X, Kan Q.. (2019) Recent development of CDK inhibitors: An overview of CDK/inhibitor co-crystal structures., 164 [PMID:30639897 ] [10.1016/j.ejmech.2019.01.003 ] 2. Lei P, Zhang J, Liao P, Ren C, Wang J, Wang Y.. (2022) Current progress and novel strategies that target CDK12 for drug discovery., 240 [PMID:35868123 ] [10.1016/j.ejmech.2022.114603 ]